MedTrace Logo

Alba - a Mobile App to Provide Bereavement Support for Adolescents in Grief

NCT06093113 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2024-11-01

No results posted yet for this study

Summary

The goal of this two-armed randomised controlled trial is to evaluate a psychosocial self-management mobile app providing bereavement support to adolescents in grief. The main questions it aims to answer are:

1. How do adolescents in grief interact with and use the app?
2. How do bereaved adolescents perceive the usability of the app?
3. Is the intervention feasible?
4. How is the meaningfulness of using the app perceived among adolescents in grief and what effect do the adolescents perceive it to have on their grieving process and everyday life?
5. Does access to the app affect symptoms of grief, complicated grief, post-traumatic stress and depression among bereaved adolescents?

Participants will:

* Test the app (intervention group) or a website containing (control group) psychoeducation for 2 months
* Fill out online questionnaires regarding their mental health (baseline, post, 6 months, 12 months).
* Fill out an online questionnaire regarding the acceptability and usability of the app (intervention group)
* Be asked to participate in narrative interviews (intervention group)

Researchers will compare the intervention group with the control group to see if the app has an effect on bereaved adolescents mental health.

Conditions

  • Complicated Grief Disorder

Interventions

BEHAVIORAL

Alba - Youth in grief

The app will build on principles of cognitive behavioural theory and therapy (CBT) and contains five main sections: Learning, Self-assessment, Manage symptoms, Find support and a Personal space.

BEHAVIORAL

Control website

The website will contain information about grief and grief reactions similar to some of the information given in the app.

Sponsors & Collaborators

  • Uppsala University

    lead OTHER

Principal Investigators

  • Josefin Sveen, PhD · Uppsala University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-10
Primary Completion
2026-05-01
Completion
2026-11-01

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06093113 on ClinicalTrials.gov